Ebola outbreak: India donates emergency pharmaceutical supplies for DR Congo response

India has donated emergency pharmaceutical supplies to support efforts to contain the Bundibugyo Ebola outbreak in eastern Democratic Republic of Congo (DRC), according to the Africa Centres for Disease Control and Prevention (Africa CDC). The consignment, delivered via Africa CDC’s Eastern Africa Regional Coordinating Centre in Uganda, includes diagnostics, therapeutics, infection prevention materials, and case management support for affected communities. The World Health Organization (WHO) declared the Ebola outbreak in DRC and Uganda a Public Health Emergency of International Concern on May 17. As of Tuesday, over 1,000 suspected infections and 220 deaths have been reported, with seven confirmed cases in Uganda, though true numbers may be higher due to challenges in tracking. The Bundibugyo strain, one of six known Ebola virus species, has caused repeated outbreaks since 2007 and was first identified in Uganda. Unlike other Ebola strains, there are no approved drugs or vaccines for Bundibugyo Ebola, complicating response efforts. The virus spreads through direct contact with infected bodily fluids, contaminated objects, or infected animals, including fruit bats, chimpanzees, and forest antelope. India’s donation aligns with its broader health partnership with African nations, including past support during the COVID-19 pandemic. Africa CDC welcomed the supplies, emphasizing their role in protecting lives and improving health security in the region. The outbreak underscores the need for rapid containment, as the virus causes severe symptoms like fever, vomiting, diarrhea, and internal bleeding in advanced stages. Africa CDC and WHO continue to coordinate response efforts, focusing on diagnostics, treatment, and infection control in high-risk areas.